Navigation Links
AlphaBio Centrix, LLC Announces a New Discovery for Programming Energetic Patches
Date:3/30/2012

LAS VEGAS, March 30, 2012 /PRNewswire/ -- AlphaBio Centrix, a Nevada-based biotech corporation, announced this week its development of a new bio-programming process – Infusion Technology. This is a term used in programming wearable TheraEX(TM) skin patches that can influence the human auric field, the energy field that surrounds all life forms.

When fully functional, this energy field is far reaching. In fact, in its basic form, it embodies seven major layers powered through seven major energy centers called Chakras.

"We are excited to share that we have discovered a way to use this auric field to influence specific bio-triggers which vibrate at a designated combination of frequencies," explains Richard Eaton, president, AlphaBio Centrix.

These frequencies communicate with, and enhance the body's natural energetic system. By wearing the TheraEX "Bio App" 24 hours a day for the duration of the protocol, the body is immersed in a corrective, informational and energetic exchange that promotes the balance of weak, disturbed and overactive energy.

AlphaBio Centrix uses a special substrate material for TheraEX ("Therapeutic Experience") that is sensitive to radio frequencies and is bonded to a non-latex woven medical pad manufactured by 3M Company. It's been formulated with an adhesive made for different types of skin conditions. This substrate material is then transformed by Infusion Technology, adding digital information onto the material.

These Bio Apps are an ideal alternative health care solution, and according to its recent research studies, mounting stress problems are causing an overwhelming effect on people's health and emotional problems. Stress factors include: today's uncertain work environment; and increasing workloads which may result in work-related injuries and health problems.

For more information on TheraEX(TM) visit: http://alphabiocentrix.com/products/thera-ex-apps-for-healing-and-frequency-medicine/ .

AlphaBio Centrix is also developing other products that are uniquely positioned to sell to homeopathic doctors and other health care professionals.

For more information on the company, visit: www.alphabiocentrix.com .

- Image 72dpi: Send2Press.com/mediaboom/12-0402-theraex_72dpi.jpg

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE AlphaBio Centrix, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Anesiva Announces Second Quarter 2008 Financial Results and Update
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
7. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
8. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... N.J. , Feb. 4, 2016 ContraVir ... focused on the development and commercialization of targeted antiviral ... CEO & Investor Conference 2016, to be held February ... Source Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... on February 10-11, 2016. James Sapirstein , ...
(Date:2/4/2016)... , Feb. 4, 2016 Sinovac Biotech ... a leading provider of biopharmaceutical products in ... of its board of directors received on February 4, ... 2016, from a consortium comprised of PKU V-Ming ( ... Biomedicine Co., Ltd., CICC Qianhai Development ( Shenzhen ...
(Date:2/4/2016)... 2016 Strasbourg, France , ... --> Strasbourg, France , to the US ... is pleased to announce that it acted as an advisor ... in Strasbourg, France , to the US ... --> Transgene (Euronext: TNG), a member of ...
(Date:2/3/2016)...   ViaCyte, Inc ., a leading, privately-held ... cell-derived islet replacement therapy for the treatment of ... that ViaCyte and Janssen Biotech, Inc., one of ... have agreed to consolidate the assets of the ... ViaCyte with an exclusive license to all BetaLogics ...
Breaking Biology Technology:
(Date:2/3/2016)... India , February 3, 2016 ... the new market research report "Automated Fingerprint Identification System ... Search, Latent Search), Application (Banking & Finance, Government, Healthcare, ... published by MarketsandMarkets, the market is expected to be ... CAGR of 21.0% between 2015 and 2020. The transformation ...
(Date:2/2/2016)... 2016 This BCC Research report provides ... reviewing the recent advances in high throughput ‘omic ... field forward. Includes forecast through 2019. ... and opportunities that exist in the bioinformatic market. ... as well as IT and bioinformatics service providers. ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
Breaking Biology News(10 mins):